Universal Technical Institute (UTI) Valuation Check After Strong Multi Month Share Price Momentum

Recent share performance and business snapshot

Universal Technical Institute (UTI) has drawn fresh attention after a recent 1 day share move of about 3.6% and a past 3 months return of roughly 40%. This has prompted a closer look at its fundamentals.

The company, a Phoenix based provider of transportation, skilled trades, and healthcare education programs, reports annual revenue of about US$855.0 million and net income of roughly US$53.7 million across its UTI and Concorde segments.

See our latest analysis for Universal Technical Institute.

While the share price slipped 3.6% over the last day to US$30.57, the 30 day share price return of 7.9% and 90 day share price return of 40.4% sit alongside a very large 5 year total shareholder return. This suggests momentum has been building over time as investors reassess the company’s growth prospects and risks.

If UTI’s move has you looking beyond a single name, this could be a good moment to widen your search with our screener of 22 top founder-led companies.

With annual revenue of about US$855.0 million, net income of roughly US$53.7 million and a share price sitting around US$30.57, is UTI still trading below what it could be worth, or is the market already accounting for future growth?

Most Popular Narrative: 18.7% Undervalued

Universal Technical Institute’s most followed narrative points to a fair value of about $37.60, comfortably above the last close at $30.57, with that gap hinging on specific growth, margin, and rating assumptions.

The recently lifted growth restrictions on Concorde Career Colleges now allow for accelerated program launches and the addition of multiple new campuses a year ahead of plan, positioning the company for faster than anticipated revenue growth and increased market share starting as early as 2026.

Read the complete narrative. Read the complete narrative.

Want to see what sits behind that gap between fair value and today’s price? Revenue expansion, changing margins, and a richer earnings multiple all play a part. The exact mix might surprise you.

Result: Fair Value of $37.60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story could change if heavier campus and program investment fails to attract enough students, or if tighter federal aid rules start to have an impact.

Find out about the key risks to this Universal Technical Institute narrative.

Another view on valuation

That 18.7% gap to the $37.60 fair value sits alongside a very different signal from plain P/E math. At $30.57, UTI trades on 31.3x earnings, compared with 17x for the wider US Consumer Services group, 26.1x for peers, and a fair ratio of 18.3x.

In practical terms, the share price already reflects a much richer earnings multiple than both the industry and the fair ratio suggest. This introduces valuation risk if sentiment cools or growth falls short. The key question is whether you think UTI has enough staying power to support that premium.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mix of optimism and valuation questions here has you thinking, do not sit on the sidelines. Instead, check the 2 key rewards to weigh those positives for yourself.

Looking for more investment ideas?

If this has sharpened your focus, do not stop at one stock; use the Simply Wall St screener to spot ideas that truly fit your aims.

• Target quality at a discount by reviewing 54 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect them.
• Prioritise resilience with 87 resilient stocks with low risk scores, where companies score well on factors that may help reduce portfolio swings.
• Get ahead of the crowd with our screener containing 23 high quality undiscovered gems, highlighting companies that have strong metrics but attract less market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com